2007
DOI: 10.1039/b705326f
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation of platinum anticancer drugs by apoferritin

Abstract: Apoferritin derived from the native protein ferritin was employed to encapsulate anticancer drugs cisplatin and carboplatin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

5
173
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 213 publications
(178 citation statements)
references
References 27 publications
5
173
0
Order By: Relevance
“…[2] It is not surprising that cisplatin, [3] the most widely used metal-based drug in the treatment of cancer, has been encapsulated in various hosts to reduce the severe side-effects associated with this drug. [4] Indeed, platinum-based drugs have been attached to various structures including carbon nanotubes, [5] proteins, [6] macrocycles [7] and dendrimers. [8] These large systems tend to accumulate preferentially in tumours due to enhanced permeability and retention (the EPR effect) of macromolecules in cancerous tissue.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[2] It is not surprising that cisplatin, [3] the most widely used metal-based drug in the treatment of cancer, has been encapsulated in various hosts to reduce the severe side-effects associated with this drug. [4] Indeed, platinum-based drugs have been attached to various structures including carbon nanotubes, [5] proteins, [6] macrocycles [7] and dendrimers. [8] These large systems tend to accumulate preferentially in tumours due to enhanced permeability and retention (the EPR effect) of macromolecules in cancerous tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Recently we combined the medicinal properties of areneruthenium complexes, a promising class of organometallic drugs, [14] with aspects of supramolecular chemistry [15] to generate a new hybrid drug-delivery system, [Ru 6 (piPrC 6 H 4 Me) 6 …”
Section: Introductionmentioning
confidence: 99%
“…[ 12,13 ] The unique architecture of AFt provides two interfaces: the outer surface of AFt can be modifi ed chemically or genetically with functional motifs [ 14 ] and the internal cavity can be used to encapsulate pharmaceutical agents such as anticancer drugs, magnetic resonance imaging (MRI), and fl uorescent imaging agents. [ 6,9,15,16 ] Recently, selective targeting and cargo delivery with heavy chain apoferritin (H-AFt) was demonstrated both in vitro [ 17 ] and in vivo. [ 18 ] Gefi tinib ("Iressa," ZD1839) is an orally active, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.…”
mentioning
confidence: 99%
“…[ 5 ] When selecting a delivery system a major consideration is controlled release of the drug to the target site at a therapeutically optimal rate. [ 1,6 ] Human ferritin is an ideal drug delivery carrier due to the nanoscale structure, and biocompatible, biodegradable, stable, nontoxic properties. [ 2,7,8 ] Ferritin consists of an apoferritin (AFt) protein cage and an iron core, and prevents accumulation of toxic levels of free iron in cells.…”
mentioning
confidence: 99%
See 1 more Smart Citation